Direct oral anticoagulants for treatment and prevention of venous thromboembolism in cancer patients

Venous thromboembolism (VTE) is a common cause of morbidity and mortality in patients with cancer. Compared with the general population, cancer patients with VTE have higher rates of both VTE recurrence and bleeding. While low molecular weight heparin (LMWH) has been the mainstay of treatment for ca...

Descripción completa

Detalles Bibliográficos
Autores principales: Song, Andrew B, Rosovsky, Rachel P, Connors, Jean M, Al-Samkari, Hanny
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6593743/
https://www.ncbi.nlm.nih.gov/pubmed/31417269
http://dx.doi.org/10.2147/VHRM.S132556

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6593743/
https://www.ncbi.nlm.nih.gov/pubmed/31417269
http://dx.doi.org/10.2147/VHRM.S132556

Ejemplares similares